Early detection saved George Barlow's life. Learn who qualifies for lung cancer screening and how it could save yours too.
The posters presented at SITC 2025 feature trial designs for the Phase 2 and Phase 3 studies in advanced NSCLC patients receiving ateganosine followed by a checkpoint inhibitor, cemiplimab (Libtayo®).
Among asymptomatic adults who underwent lung cancer screening, risks for all-cause, COPD and cardiovascular disease mortality ...
People are eligible for a low-dose CT scan to look for lung cancer if they have a 20 pack-year or more smoking history, ...
Berlin: Bayer has received accelerated approval from the U.S. Food and Drug Administration (FDA) for HYRNUO ...
Dr. Bharat said the current recommendation for an annual lung cancer screening is for adults 50 and up who are smokers or ...
By Elizabeth Chapin University of Kentucky Kentucky has historically led the nation in lung cancer rates, but the statistics ...
A new randomized trial from North Carolina suggests that digital tools like mPATH may slightly boost participation in CT lung ...
November is Lung Cancer Awareness Month, and Mercy Hospital is shining a spotlight on the life-saving power of early ...
Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...
Colette Smith of the Bronx was diagnosed with lung cancer, despite never smoking. Her survival story is central to her push ...
Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback